Spruce Biosciences, Inc. (SPRB) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $401.46M; Retained Earnings (Accumulated Deficit)USD $-317.73M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $336.15M; Retained Earnings (Accumulated Deficit)USD $-301.50M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $331.75M; Retained Earnings (Accumulated Deficit)USD $-289.23M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $279.97M; Retained Earnings (Accumulated Deficit)USD $-274.59M.
Spruce Biosciences, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $0.00 | $401.46M | $-317.73M | $83.73M | 3 month · $871.00K 6 month · $1.56M | 6 month · $3.72M | (m) | (m) |
| 2026-03-31 | $0.00 | $0.00 | $336.15M | $-301.50M | $34.65M | 3 month · $689.00K | 3 month · $3.72M | (m) | (m) |
| 2025-12-31 | $0.00 | $0.00 | $331.75M | $-289.23M | $42.52M | 12 month · $2.57M | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $0.00 | $279.97M | $-274.59M | $5.39M | 3 month · $415.00K 9 month · $882.00K | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $0.00 | $279.56M | $-266.38M | $13.18M | 3 month · $-77.00K 6 month · $-467.00K | 6 month · $0.00 | (m) | (m) |
| 2025-03-31 | $0.00 | $4.00K | $279.63M | $-264.31M | $15.32M | 3 month · $544.00K | 3 month · $0.00 | (m) | (m) |
| 2024-12-31 | $0.00 | $0.00 | $279.09M | $-250.27M | $28.82M | 12 month · $5.35M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $4.00K | $278.34M | $-226.71M | $51.64M | 3 month · $1.14M 9 month · $4.39M | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $4.00K | $277.20M | $-218.04M | $59.17M | 3 month · $1.69M 6 month · $3.25M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $4.00K | $275.48M | $-208.86M | $66.62M | 3 month · $1.56M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $4.00K | $273.74M | $-197.23M | $76.51M | 12 month · $4.62M | (m) | $0.00 | (m) |
| 2023-09-30 | $0.00 | $4.00K | $272.66M | $-187.28M | $85.38M | 3 month · $1.12M 9 month · $3.40M | (m) | $-3.00K | (m) |
| 2023-06-30 | $0.00 | $4.00K | $271.54M | $-174.93M | $96.56M | 3 month · $1.22M 6 month · $2.28M | (m) | $-55.00K | (m) |
| 2023-03-31 | $0.00 | $4.00K | $270.29M | $-162.10M | $108.00M | 3 month · $1.06M | (m) | $-188.00K | (m) |
| 2022-12-31 | $0.00 | $3.00K | $218.35M | $-149.31M | $68.49M | 12 month · $3.63M | (m) | $-558.00K | (m) |
| 2022-09-30 | $0.00 | $3.00K | $217.51M | $-138.17M | $78.47M | 3 month · $783.00K 9 month · $2.83M | (m) | $-873.00K | (m) |
| 2022-06-30 | $0.00 | $3.00K | $216.73M | $-126.77M | $89.12M | 3 month · $905.00K 6 month · $2.05M | (m) | $-845.00K | (m) |
| 2022-03-31 | $0.00 | $3.00K | $215.83M | $-114.89M | $100.24M | 3 month · $1.14M | (m) | $-693.00K | (m) |
| 2021-12-31 | $0.00 | $3.00K | $214.69M | $-103.13M | $111.37M | 12 month · $3.96M | (m) | $-184.00K | (m) |
| 2021-09-30 | (m) | $3.00K | $213.68M | $-93.95M | $119.72M | 3 month · $1.03M 9 month · $3.16M | (m) | $-16.00K | (m) |
| 2021-06-30 | (m) | $3.00K | $212.63M | $-82.50M | $130.11M | 3 month · $1.01M 6 month · $2.13M | (m) | $-29.00K | (m) |
| 2021-03-31 | (m) | $2.00K | $211.45M | $-70.73M | $140.72M | 3 month · $1.12M | (m) | (m) | (m) |
| 2020-12-31 | (m) | $2.00K | $210.27M | $-60.84M | $149.43M | 12 month · $755.00K | (m) | (m) | (m) |
| 2020-09-30 | (m) | $1.00K | $1.06M | $-52.50M | $-51.44M | 3 month · $218.00K 9 month · $346.00K | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-42.12M | 3 month · $96.00K 6 month · $128.00K | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-35.77M | 3 month · $32.00K | (m) | (m) | (m) |
| 2019-12-31 | (m) | $1.00K | $664.00K | $-31.30M | $-30.64M | 12 month · $196.00K | (m) | (m) | 12 month · $57.00K |
| 2019-09-30 | (m) | (m) | (m) | (m) | $-27.52M | 3 month · $62.00K | (m) | (m) | 3 month · $37.00K |
| 2019-06-30 | (m) | (m) | (m) | (m) | $-25.07M | 3 month · $77.00K | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | $-21.91M | 3 month · $15.00K | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $-17.80M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |